Abstract
Citrobacter freundii is an opportunistic pathogen responsible for many urinary tract infections acquired in hospitals and is thus a concern for public health. C. freundii phage Stevie might prove beneficial as a treatment against these infections. The complete genome of Stevie and its key features are described here.
GENOME ANNOUNCEMENT
Citrobacter, a Gram-negative bacteria, includes many opportunistic pathogens. C. freundii causes urinary and respiratory tract infections, many of which have been found to be resistant to a number of antibiotics (1, 2). This makes bacteriophages infecting C. freundii, such as siphophage Stevie, described here, of particular interest for combating multi-drug resistance (3).
Bacteriophage Stevie was isolated from a dirt sample collected in College Station, TX. Phage DNA was sequenced in an Illumina MiSeq 250-bp paired-end run with a 550-bp insert library at the Genomic Sequencing and Analysis Facility at the University of Texas (Austin, TX). Quality-controlled trimmed reads were assembled to a single contig at 20.9 fold coverage using Velvet version 1.2.10. Genes were predicted using GeneMarkS (4) and corrected using software tools available on the Center for Phage Technology (CPT) Galaxy instance (https://cpt.tamu.edu/galaxy-public/) (5–7). Morphology was determined using transmission electron microscopy performed at the Texas A&M University Microscopy and Imaging Center.
Stevie is a T1-like phage with a 49,759-bp partially permuted genome, G+C content of 43.7%, 91.5% coding density, and 91 predicted coding sequences. Stevie shares 47.7, 62.8, and 44.2 percent nucleotide sequence identity to siphophages T1 (NC_005833), TLS (NC_009540), and FSL SP-030 (NC_021779), respectively, as determined by Emboss Stretcher (8). It has an abundance of rho-independent terminators, a distinguishing feature of T1-like phages, with 21 predicted in its genome compared to the 17 found in phage T1 (9). Sixteen occurrences of a 22-bp repeat sequence (consensus-VWATAGCAYKWWTTGYTAAAAV) were identified in the sequence of Stevie. A comparable repeat with 20 occurrences was identified in the T1 genome (9). The repeat sequence is asymmetric, predominantly intergenic, and oriented in one direction with respect to the direction of transcription. A 13-bp repeat with similar features was described in mycobacteriophage L5 as a stoperator involved in the maintenance of transcriptional silence of the integrated prophage (10). The role these repeats play in the lytic lifestyle of T1 and Stevie is unknown.
Genes encoding T1-like morphogenesis proteins include the prohead protease, major capsid protein, tail fibers, tail assembly proteins, tape measure protein, and tape measure chaperones (complete with a conserved translational frameshift) (11). Few DNA replication/recombination proteins were identified (single-strand annealing protein, single-strand binding protein, primase, helicase, and an endonuclease). Stevie encodes a DNA (N6-adenine)-methyltransferase and presumably methylates its DNA-like phage T1 (12, 13). Stevie uses a headful DNA-packaging mechanism as determined by homology of TerL to large terminase proteins of phages with known pac-type strategies (14).
Similar to T1-like phage TLS, Stevie encodes a T4 Stp-like peptide that protects the phage from specific host restriction enzymes (15). In T4, the Stp-mediated restriction enzyme protection activates a host tRNALys-specific anticodon nuclease (ACNase), the action of which is mitigated by phage encoded polynucleotide kinase, also present in the Stevie genome. The lysis cassette consists of a predicted (class-II) pinholin (6), a R21-like signal anchor release (SAR) lysozyme (16, 17), and a unimolecular spanin (18).
Nucleotide sequence accession number.
The genome sequence of phage Stevie was deposited in GenBank under the accession no. KM236241.
ACKNOWLEDGMENTS
This work was supported primarily by funding from award EF-0949351, “Whole Phage Genomics: A Student-Based Approach,” from the National Science Foundation. Additional support came from the Center for Phage Technology, an Initial University Multidisciplinary Research Initiative supported by Texas A&M University and Texas AgriLife, and from the Department of Biochemistry and Biophysics.
We are grateful for the advice and support of the CPT staff.
This announcement was prepared in partial fulfillment of the requirements for Bich464 Phage Genomics, an undergraduate course at Texas A&M University.
Footnotes
Citation Shaw JP, Aviles Medina CA, Chen Y, Luna AJ, Hernandez AC, Kuty Everett GF. 2015. Complete genome of Citrobacter freundii siphophage Stevie. Genome Announc 3(1):e01434-14. doi:10.1128/genomeA.01434-14.
REFERENCES
- 1.Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. 1996. Bacteremia due to Citrobacter species: significance of primary intraabdominal infection. Clin Infect Dis 23:543–549. doi: 10.1093/clinids/23.3.543. [DOI] [PubMed] [Google Scholar]
- 2.Kim PW, Harris AD, Roghmann MC, Morris JG Jr, Strinivasan A, Perencevich EN. 2003. Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible Citrobacter freundii in hospitalized patients. Antimicrob Agents Chemother 47:2882–2887. doi: 10.1128/AAC.47.9.2882-2887.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. 2011. Phage treatment of human infections. Bacteriophage 1:66–85. doi: 10.4161/bact.1.2.15845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Besemer J, Lomsadze A, Borodovsky M. 2001. GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 29:2607–2618. doi: 10.1093/nar/29.12.2607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. doi: 10.1186/1471-2105-10-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Das U, Daugherty L, Duquenne L, Finn RD, Gough J, Haft D, Hulo N, Kahn D, Kelly E, Laugraud A, Letunic I, Lonsdale D, Lopez R, Madera M, Maslen J, McAnulla C, McDowall J, Mistry J, Mitchell A, Mulder N, Natale D, Orengo C, Quinn AF, Selengut JD, Sigrist CJ, Thimma M, Thomas PD, Valentin F, Wilson D, Wu CH, Yeats C. 2009. InterPro: the integrative protein signature database. Nucleic Acids Res 37:D211–D215. doi: 10.1093/nar/gkn785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zhang N, Zheng C, Bryant SH. 2011. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res 39:D225–D229. doi: 10.1093/nar/gkq1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Myers EW, Miller W. 1988. Optimal alignments in linear space. Comput Appl Biosci 4:11–17. doi: 10.1093/bioinformatics/4.1.11. [DOI] [PubMed] [Google Scholar]
- 9.Roberts MD, Martin NL, Kropinski AM. 2004. The genome and proteome of coliphage T1. Virology 318:245–266. doi: 10.1016/j.virol.2003.09.020. [DOI] [PubMed] [Google Scholar]
- 10.Brown KL, Sarkis GJ, Wadsworth C, Hatfull GF. 1997. Transcriptional silencing by the mycobacteriophage L5 repressor. EMBO J 16:5914–5921. doi: 10.1093/emboj/16.19.5914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Xu J, Hendrix RW, Duda RL. 2014. Chaperone-protein interactions that mediate assembly of the bacteriophage lambda tail to the correct length. J Mol Biol 426:1004–1018. doi: 10.1016/j.jmb.2013.06.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schneider-Scherzer E, Auer B, de Groot EJ, Schweiger M. 1990. Primary structure of a DNA (N6-adenine)-methyltransferase from Escherichia coli virus T1. DNA sequence, genomic organization, and comparative analysis. J Biol Chem 265:6086–6091. [PubMed] [Google Scholar]
- 13.Wagner EF, Auer B, Schweiger M. 1979. Development of Escherichia coli virus T1: escape from host restriction. J Virol 29:1229–1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Casjens SR, Gilcrease EB. 2009. Determining DNA packaging strategy by analysis of the termini of the chromosomes in tailed-bacteriophage virions. Methods Mol Biol 502:91–111. doi: 10.1007/978-1-60327-565-1_7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Penner M, Morad I, Snyder L, Kaufmann G. 1995. Phage T4-coded Stp: double-edged effector of coupled DNA and tRNA-restriction systems. J Mol Biol 249:857–868. doi: 10.1006/jmbi.1995.0343. [DOI] [PubMed] [Google Scholar]
- 16.Xu M, Struck DK, Deaton J, Wang IN, Young R. 2004. A signal-arrest-release sequence mediates export and control of the phage P1 endolysin. Proc Natl Acad Sci USA 101:6415–6420. doi: 10.1073/pnas.0400957101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sun Q, Kuty GF, Arockiasamy A, Xu M, Young R, Sacchettini JC. 2009. Regulation of a muralytic enzyme by dynamic membrane topology. Nat Struct Mol Biol 16:1192–1194. doi: 10.1038/nsmb.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Summer EJ, Berry J, Tran TA, Niu L, Struck DK, Young R. 2007. Rz/Rz1 lysis gene equivalents in phages of Gram-negative hosts. J Mol Biol 373:1098–1112. doi: 10.1016/j.jmb.2007.08.045. [DOI] [PubMed] [Google Scholar]